Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
基本信息
- 批准号:8334637
- 负责人:
- 金额:$ 40.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2016-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAgeAlbuminsAlbuminuriaAnimal ModelAreaBiochemicalCell physiologyCellsChronicChronic Kidney FailureDataDevelopmentDiabetes MellitusDiseaseDisease ProgressionDisease modelEvaluationIndividualKidneyLaboratoriesLeadLigandsLocationMediatingMembraneMethodsMicroscopyModelingPermeabilityPhosphorylationPhotonsPhysiologicalPlayPost-Translational Protein ProcessingProcessProtein DynamicsProteinsProteinuriaProteomicsRat StrainsRattusRegulationRoleSmall Interfering RNASpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStreptozocinSurfaceTechniquesTestingToxic effectTubular formationUrineWistar Ratsbasolateral membraneclinically relevantglycosylationinterestneonatal Fc receptornovel therapeutic interventionpre-clinicaltraffickingtranscytosisuptakeurinary
项目摘要
DESCRIPTION (provided by applicant): While the clinical relevance of proteinuria, and especially albuminuria, has been well documented the quantitative mechanistic contribution or role of different barrier components to albuminuria remains an area of considerable excitement and debate. Recent data from several laboratories utilizing different scientific approaches have delineated a potential role of proximal tubules in albumin reabsorption and reclamation as another important determinant of the urinary barrier to albuminuria. Therefore, the present application proposes to dissect apart and quantify glomerular and proximal tubule contributions to albuminuria under physiologic and disease conditions in a longitudinal fashion in the same rats. Structural, functional and mechanistic observations will be interrelated to advance our present understanding of this clinically important phenomenon. Our Overall Hypothesis is that both glomerular permeability and proximal tubule cells play fundamental, physiologic, synergistic, interactive and inducible roles to try and maintain the physiological state and minimize albuminuria. We further hypothesize that acute or chronic alterations in glomerular albumin permeability or in proximal tubule albumin reclamation can directly affect albuminuria. To directly evaluate this hypothesis we have developed the necessary techniques, approaches and animal models to dissect, quantify, understand and interrelate the role of acute and chronic changes in glomerular permeability and proximal tubular cell reabsorption and transcytosis of filtered albumin.
描述(由申请人提供):虽然蛋白尿,特别是蛋白尿的临床相关性已经被很好地记录下来,但不同屏障成分对蛋白尿的定量机制贡献或作用仍然是一个相当令人兴奋和争论的领域。几个实验室利用不同科学方法的最新数据描绘了近端小管在白蛋白重吸收和回收中的潜在作用,它是白蛋白尿尿液屏障的另一个重要决定因素。因此,本申请建议以纵向方式解剖和量化同一大鼠在生理和疾病条件下肾小球和近端小管对蛋白尿的贡献。结构、功能和机制的观察将相互关联,以促进我们目前对这一临床重要现象的理解。我们的总体假设是,肾小球通透性和近端小管细胞都发挥着基础的、生理学的、协同的、相互作用的和可诱导的作用,试图维持生理状态,最大限度地减少蛋白尿。我们进一步假设,肾小球白蛋白通透性或近端小管白蛋白回收的急性或慢性改变可以直接影响蛋白尿。为了直接评估这一假说,我们开发了必要的技术、方法和动物模型来解剖、量化、理解和相互联系肾小球通透性的急性和慢性变化以及近端肾小管细胞重吸收和过滤白蛋白的跨细胞作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce A Molitoris其他文献
Technology Insight: biomarker development in acute kidney injury—what can we anticipate?
技术洞察:急性肾损伤中的生物标志物开发——我们可以期待什么?
- DOI:
10.1038/ncpneph0723 - 发表时间:
2008-01-29 - 期刊:
- 影响因子:39.800
- 作者:
Bruce A Molitoris;Vyacheslav Y Melnikov;Mark D Okusa;Jonathan Himmelfarb - 通讯作者:
Jonathan Himmelfarb
Bruce A Molitoris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce A Molitoris', 18)}}的其他基金
Mechanisms and Key Molecular Target of Gentamacin Toxicity
庆大霉素毒性机制和关键分子靶点
- 批准号:
8141638 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
- 批准号:
8537445 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
- 批准号:
8447794 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Mechanisms and Key Molecular Target of Gentamacin Toxicity
庆大霉素毒性机制和关键分子靶点
- 批准号:
8391642 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
- 批准号:
8917198 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
- 批准号:
8731203 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States
疾病状态下的近曲小管白蛋白转运
- 批准号:
8235552 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Proximal Tubule Albumin Transport in Disease States.
疾病状态下的近端小管白蛋白转运。
- 批准号:
9309881 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Mechanisms and Key Molecular Target of Gentamacin Toxicity
庆大霉素毒性机制和关键分子靶点
- 批准号:
8762413 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
Mechanisms and Key Molecular Target of Gentamacin Toxicity
庆大霉素毒性机制和关键分子靶点
- 批准号:
8598026 - 财政年份:2011
- 资助金额:
$ 40.72万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.72万 - 项目类别:
Research Grant